Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today announced the launch of its TrailBlazer™ Tag and TrailBlazer StarBright™ Dye Label Kits.

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®? (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous infusion) as a ...

Maharashtra has so far reported two suspected deaths and 127 suspected cases of the rare neurological condition ...

Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.

GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...

An increased prevalence of chronic kidney disease is expected to fuel growth in the nulojix market. The rise in chronic kidney disease is a long-term condition where the kidneys gradually lose their ...

Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

The deal size was increased to $150M from $125M and priced below last closing price of $9.35. JPMorgan, TD Cowen, Leerink and Guggenheim are ...

JPMorgan, TD Cowen, Leerink and Guggenheim are acting as joint book running managers for the offering.Invest with Confidence: Follow TipRanks' ...